Your trusted source for investing success
Trump’s policies are affecting gold. You should know what’s going on. Click here to get our FREE report.
Click here to get your free report!Discover what the experts see coming in the Age of Trump with our INN Insider's Report free of charge! Includes expert insights into Trump and his effect on mining and gold.
By Shelly Kumar
High Hampton Holdings Corp. (CSE:HC) (“High Hampton” or the “Company“) is pleased to provide an update on its California operations. The Company has engaged Infrastructure Engineers, a multi-disciplinary municipal engineering firm located in Brea, California, to assemble and assist with the filing and processing of a conditional use permit (CUP) application for the Company’s 100%
By Melissa Shaw
Potash Corporation of Saskatchewan (PotashCorp) (TSX and NYSE:POT) and Agrium (TSX and NYSE: AGU) today announced that the Canadian Competition Bureau (“CCB”) has granted unconditional regulatory approval for the proposed merger of equals by issuing a no-action letter dated September 11, 2017.
The CCB concluded that the proposed transaction is not likely to
By Shelly Kumar
CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) today released its financial results for the three and nine months ended July 31, 2017.
Highlights
Sales of $4.8 million in the quarter were 80 per cent higher than in the comparable period of the prior year and were 29 per cent higher than the second quarter of 2017.
Potash Corporation of Saskatchewan Inc. (TSX:POT,NYSE:POT) and Agrium Inc. (TSX:AGU,NYSE:AGU) provided an updated on the status of their proposed merger. Both parties “remain highly confident” that the deal will close, but now expect that to happen in Q4 2017.
By Shelly Kumar
Friday Night Inc. (the “Company”) (CSE:TGIF) (FRANKFURT:1QF) is pleased to provide an update on its Nevada operations and expansion plans.
In the month of August, Alternative Medicine Association (“AMA”) and Infused MFG., both 91% owned assets, continued to see strong product demand in the recreational cannabis market. As a result both
For the second time this week the FDA sends refusal letter for a medical candidate.In doing so, it sent SteadyMed’s stock tumbling down.
OncBioMune Pharmaceuticals announced the protocol for their planned Phase II study of ProscaVax treating prostate cancer is being reviewed by the respective regulatory committee.
By Shelly Kumar
Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) announces the world’s first clinical study on human volunteers of cannabidiol (CBD) within Lexaria’s high absorption TurboCBD™ product, to evaluate its effects on both cardiovascular health and cognitive function.
The study will have a double-blind and placebo controlled cross-over design measuring effects both after a single dose,
Here, the Investing News Network looks at publicly traded medical device and technology companies listed on the TSX.
Abeona Therapeutics announced the US Food and Drug Administration granted a Breakthrough Therapy designation status to the company’s EB-101 gene therapy program.
By Shelly Kumar
Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) announces it is attending and exhibiting at the Investorshub International Cannabis Conference in Los Angeles on September 1-2, held at the JW Marriott downtown. Chris Bunka, CEO of Lexaria, will be giving a presentation on the latest technology available to benefit the cannabis industry.
On September 7-8, Lexaria
By Shelly Kumar
International Frontier Resources Corporation (TSXV:IFR,OTCQB:IFRTF) reported today its financial and operating results for the three and six months ended June 30, 2017. Selected financial and operational information is set out below and should be read in conjunction with IFR’s June 30, 2017 interim financial statements and the related management’s discussion and
Peregrine Diamonds Ltd. (TSX:PGD) (“Peregrine” or “the Company”) is pleased to announce the completion of three diamond drill holes totaling 1,474 metres drilled at its 100%-owned Chidliak Diamond Project (“Chidliak”) near Iqaluit, Nunavut, Canada. Core hole CHI-050-17-DD36 (“DD36”) is a 378 metre vertical hole that intersected kimberlite from 4.5 to
A new study evaluating the clinical trials medical devices go through as part of their redesigns or updates found these can often rely on “inadequate or potentially biased data.”
By Shelly Kumar
Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP), announces it has received US$91,443.50 from the exercise of warrants and options previously granted. The stock warrants were exercised at the price of US$0.14 and the stock options were exercised at US$0.2273, for a total of 636,025 common shares being issued. All warrants and options are being
Dynavax Technologies saw its stock jump over 70 percent on Monday thanks to a favorable review from the US Food and Drug Administration advisory committee for their hepatitis B vaccine.
On his first three months as commissioner of the Food and Drug Administration, Scott Gottlieb has already taken significant steps to spark competition in the pharmaceutical space and help bring down the costs of some vital products.
By Jocelyn Aspa
Digerati Technologies (OTCQB:DTGI) has announced an update on its acquisition of T3 Communications, a provider of cloud communication and broadband solutions.
As quoted in the press release:
On May 9, 2017, the Company announced that it had entered into a definitive agreement to acquire T3 and, subject to regulatory approval, anticipated closing
Teck Resources Limited (TSX:TECK.A and TECK.B)(NYSE:TECK) (“Teck”) reported profit attributable to shareholders of $577 million ($1.00 per share) in the second quarter compared with $15 million ($0.03 per share) a year ago.
“I’m pleased with our results,” said Don Lindsay, President and CEO. “We generated adjusted EBITDA of $1.3 billion in
By Jocelyn Aspa
Bee Vectoring Technologies (TSXV:BEE) has announced it has received official organic certification in the US and its proprietary formulation of Vectorite with VCT-CR7 is listed by the Organic Materials Review Institute (OMRI).
As quoted in the press release:
The listing means the product meets the US Department of Agriculture’s (USDA) guidelines under
